UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
24 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

UMN Pharma Inc. (UMN) is a biopharmaceutical company that manufactures therapeutic for diabetes, muscular dystrophy and influenza. The companys products comprise UMN-0502, UMN-0501, UMN-0901, UMN-2003 and UMN-2002. Its UMN-0502 is a seasonal influenza vaccine. Its UMN-0501 and UMN-0901 are used as pandemic influenza vaccines. It provides UMN-2003 product, a norovirus VLP - rotavirus VP6 non-live injectable trivalent vaccine for preventing two major causative agents of acute gastroenteritis in one injection. It partners with universities and pharmeceutical compnias for biopharmaceuticals manufacturing, biosimilars business and otehrs. UMN is headquartered in Yokohama, Japan

UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the comp

  
Source:
Document ID
GDPH139967D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
UMN Pharma Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
UMN Pharma Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
UMN Pharma Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
UMN Pharma Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
UMN Pharma Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
UMN Pharma Inc., Pharmaceuticals &Healthcare, Deal Details1011
  Partnerships101
    Daiichi Sankyo and UMN Pharma Enter into Research Agreement for Norovirus Vaccine101
    Catalent Pharma Solutions Enters Into Agreement With UMN Pharma For Biosimilar Development111
    UMN Pharma Enters Into Co-Development Agreement With API121
    UMN Pharma Forms Joint Venture With IHI131
  Licensing Agreements141
    UMN Pharma Enters Into Licensing Agreement With Ildong Pharma For Influenza Vaccine142
    UMN Pharma Enters Into Licensing Agreement With University of Tampere Vaccine Research Center161
    Protein Sciences Expands Its Licensing Agreement With UMN Pharma For FluBlok And PanBlok171
    Astellas Pharma Enters Into Licensing Agreement With UMN Pharma182
  Equity Offering201
    UMN Pharma Completes Private Placement Of Shares For US$10 Million201
UMN Pharma Inc. - Key Competitors211
Key Employees221
Locations And Subsidiaries231
  Head Office231
  Other Locations &Subsidiaries231
Appendix241
  Methodology241
  About GlobalData241
  Contact Us241
  Disclaimer241

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/UMN-Pharma-Inc-4585-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6701>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/UMN-Pharma-Inc-4585-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6701>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research